ArticleJBRA assisted reproduction2025
Influence of infertility-associated autoantibodies and sexually transmitted infections on implantation success rates after ICSI.
Article in JBRA assisted reproduction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePreimplantation genetic testing improves rates of assisted reproductive technologies success by selecting euploid embryos, reducing implantation failures and miscarriages. However, some factors in women may also impact outcomes, though systematic studies on autoantibodies and implantation success are lacking. In this study, we determined the presence of specific autoantibodies related to infertility and specific antibodies to sexually transmitted infections pathogens among women undergoing intracytoplasmic sperm injection including preimplantation genetic testing and investigated their effect on implantation success.
methodsPlasma samples from 86 women undergoing in vitro fertilization procedures by intracytoplasmic sperm injection and preimplantation genetic testing were tested for the presence of specific autoantibodies against the ovaries, placenta, uterus, and sperm as well as specific antibodies against Mycoplasma hominis, Ureaplasma urealyticum, Treponema pallidum, Chlamydia Trachomatis, Herpes simplex virus 1 and Herpes simplex virus 2. The prevalences of these antibodies were compared between women with successful versus unsuccessful implantation after embryo transfer.
resultsThe prevalence of anti-Ureaplasma urealyticum antibodies was significantly higher (Fisher's exact test, p=0.028) in women with unsuccessful implantation after intracytoplasmic sperm injection procedures (62.0%), compared to women with successful implantation (36.1%).
conclusionsThe results of this study indicate that a past infection with Ureaplasma urealyticum might lead to an increased risk for implantation failure after intracytoplasmic sperm injection procedures. Thus, the detection of IgG antibodies against Ureaplasma urealyticum could potentially be used in the future to identify women with an increased risk for implantation failure. However, our findings need to be confirmed in larger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.